Improving Access to Control of Diseases for Women (IMPACD)

The aim of this study is to evaluate the feasibility and acceptability of the model of delivering CHW-driven home-based comprehensive NCD control services aimed to prevent premature deaths from cardio-vascular diseases, stroke and breast, cervix and oral cancers in the hard-to-reach women.

Study Overview

Detailed Description

Specific objectives of this study are the evaluation of:

  1. The social, cultural and behavioral factors that impact the uptake of the NCD control services among rural women using the Rapid Assessment, Response and Evaluation (RARE) approach;
  2. The feasibility and acceptability of the strategy to deliver the following NCD control services to the rural women at their homes by the trained CHWs:

    • Counselling of the tobacco habitués to give up the practice
    • Early detection of hypertension and diabetes to ensure prompt and regular treatment
    • Creating breast awareness and ensuring access to prompt diagnosis and treatment of the women with symptoms suggestive of breast cancer
    • Screening for cervical cancer by self-collected HPV test and ensuring prompt treatment of screen detected precancers and cancers
    • Screening of the habitual tobacco/alcohol users for oral cancer by OVE and ensuring prompt treatment of screen detected precancers and cancers

Study Type

Interventional

Enrollment (Actual)

1200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rajasthan
      • Udaipur, Rajasthan, India, 313001
        • GBH Cancer Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women between 30 to 60 years residing in the villages of the Gogunda block in the district of Udaipur in Rajasthan, India, will be eligible to participate.

Exclusion Criteria:

  • Women suffering from debilitating illnesses, pregnant women and women refusing to participate will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Outcomes of the questionnaire survey 1/5
Time Frame: 1 year
proportion of the participants who know about the adverse effect of smoking, chewing tobacco and consuming alcohol on health in general and NCDs in particular
1 year
Outcomes of the questionnaire survey 2/5
Time Frame: 1 year
proportion of the participants who know about the common NCDs including cancers and their early symptoms
1 year
Outcomes of the questionnaire survey 3/5
Time Frame: 1 year
proportion of the participants with a diagnosis of hypertension who adhere to the treatment advised
1 year
Outcomes of the questionnaire survey 4/5
Time Frame: 1 year
proportion of the participants with a diagnosis of diabetes who adhere to the treatment advised
1 year
Outcomes of the questionnaire survey 5/5
Time Frame: 1 year
proportion of the participants with a diagnosis of cancer who adhere to the treatment advised
1 year
NCD Screening study 1/11
Time Frame: 1 year
screen positivity - proportion of the screened participants detected to have high blood pressure
1 year
NCD Screening study 2/11
Time Frame: 1 year
screen positivity - proportion of the screened participants detected to have high BMI
1 year
NCD Screening study 3/11
Time Frame: 1 year
screen positivity - proportion of the screened participants detected to have abnormal HPV detection test
1 year
NCD Screening study 4/11
Time Frame: 1 year
screen positivity - proportion of the screened participants detected to have abnormal oral examination test
1 year
NCD Screening study 5/11
Time Frame: 1 year
screen positivity - proportion of the screened participants detected to have abnormal visual examination test
1 year
NCD Screening study 6/11
Time Frame: 1 year
compliance to further assessment - proportion of screen positive participants undergoing further assessment at the primary health center or at the hospital
1 year
NCD Screening study 7/11
Time Frame: 1 year
positive predictive values of further assessment - proportion of participants with confirmed diagnosis of hypertension among those assessed for high BP
1 year
NCD Screening study 8/11
Time Frame: 1 year
positive predictive values of further assessment - proportion of participants with confirmed diabetes among those assessed for high sugar
1 year
NCD Screening study 9/11
Time Frame: 1 year
positive predictive values of further assessment - proportion of participants with confirmed cervical neoplasias on colposcopy and/or biopsy among those assessed for positive HPV test
1 year
NCD Screening study 10/11
Time Frame: 1 year
positive predictive values of further assessment - proportion of participants with confirmed oral premalignant and malignant lesions on examination and/or biopsy among those assessed for positive oral examination
1 year
NCD Screening study 11/11
Time Frame: 1 year
positive predictive values of further assessment - proportion of participants with confirmed visual premalignant and malignant lesions on examination and/or biopsy among those assessed for positive visual examination
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
effect of different participant characteristics on the final diagnosis of hypertension and diabetes using multivariate analysis
Time Frame: 1 year
effect of different participant characteristics on the final diagnosis of hypertension and diabetes using multivariate analysis
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

August 1, 2018

Study Completion (Actual)

July 1, 2019

Study Registration Dates

First Submitted

August 17, 2017

First Submitted That Met QC Criteria

July 20, 2018

First Posted (Actual)

July 30, 2018

Study Record Updates

Last Update Posted (Actual)

September 5, 2021

Last Update Submitted That Met QC Criteria

August 31, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Cancer

Clinical Trials on Evaluation of social, cultural and behavioral factors

3
Subscribe